Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
Kim HS, Lee H, Shin SJ, Beom SH, Jung M, Bae S, Lee EY, Park KH, Choi YY, Son T, Kim HI, Cheong JH, Hyung WJ, Park JC, Shin SK, Lee SK, Lee YC, Koom WS, Lim JS, Chung HC, Noh SH, Rha SY, Kim H, Paik S.
Kim HS, et al. Among authors: lee ey, lee h, lee sk, lee yc.
Oncotarget. 2017 Jun 13;8(24):38389-38398. doi: 10.18632/oncotarget.16409.
Oncotarget. 2017.
PMID: 28418920
Free PMC article.
Clinical Trial.